Skip to content

NS.MEDIC

Active
Private limited companyfounded 20233 yrs activeAvenue Scott (Sir Walter) 17, 1410 Waterloo, BelgiumKBO/BCE: BE 0799.234.072
Summary

NS.MEDIC has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €284,737 and a net result of €184,040. The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability100=
Solvency100=
Growth78
Track record94
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25,000 at 30 days acceptable
Liquidity ample (current ratio 40.92 against 11.6 in 2023; short-term debt: 2.3% and cash: 58.8% of total assets), and 2.3% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 3 years 0 10 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
97.7%
Return on assets
63.1%
Age of the figures
21 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
32 d early
2024
9 d early
2023
9 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 17 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 22 July (3 of the last 3 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

NS.MEDIC was incorporated on 7 March 2023 as a Private limited company.1 The company has filed 3 sets of annual accounts, the latest for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€284,737▲ 183%
2023 · €100,697
Total assets
€291,572▲ 168%
2023 · €108,754
Net result
€184,040▲ 86.5%
2023 · €98,697
Working capital
€272,861▲ 220%
2023 · €85,379
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20232024
Operating result€127,665-€245,667▲ 92.4%
Net result€98,697within the sector's middle half-€184,040above the sector's middle half▲ 86.5%
Equity€100,697within the sector's middle half-€284,737within the sector's middle half▲ 183%
Total assets€108,754below the sector's middle half-€291,572within the sector's middle half▲ 168%
Debt€8,057-€6,835▼ 15.2%
Working capital€85,379within the sector's middle half-€272,861above the sector's middle half▲ 220%
Solvency92.6%above the sector's middle half-97.7%above the sector's middle half▲ 5.1pp
Current ratio11.60above the sector's middle half-40.92above the sector's middle half▲ 29.33
Return on assets (ROA)90.8%above the sector's middle half-63.1%above the sector's middle half▼ 27.6pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100,000€200,000Operating result 2023: €127,665€127,665Net result 2023: €98,697€98,697Operating result 2024: €245,667€245,667Net result 2024: €184,040€184,04020232024€0€100,000€200,000Operating result 2023: €127,665€128,000Net result 2023: €98,697€98,700Operating result 2024: €245,667€246,000Net result 2024: €184,040€184,00020232024
The operating result rises in 2024; 2024 is 92% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €291,572
Fixed assets €11,876 ▼ 22.5%
Current assets €279,696 ▲ 199%
Equity and liabilities €291,572
Equity €284,737 ▲ 183%
Debt €6,835 ▼ 15.2%
Debt's share of the balance-sheet total falls from 7.4% to 2.3%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€252,664▲
2023 · €132,542
Cash flow
€191,036▲
2023 · €103,574
Debt to equity
0.02▼
2023 · 0.08
ROE
64.6%▼
2023 · 98.0%
Interest coverage
2937.95▲
2023 · 1440.37
Debt ≤ 1 year
€6,835▼
2023 · €8,057
Income taxes
€61,542▲
2023 · €28,876
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
96% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,340 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 34 lines
Balance sheet Code20232024
Assets
Total assets20/58€108,754€291,572▲
Fixed assets21/28€15,318€11,876▼
Tangible fixed assets22/27€15,318€11,876▼
Furniture and vehicles24€15,318€11,876▼
Current assets29/58€93,436€279,696▲
Amounts receivable within one year40/41€0€2,999▲
Trade receivables40€0-
Other amounts receivable41-€2,999
Current investments50/53-€80,000
Cash at bank and in hand54/58€77,111€171,455▲
Deferred charges and accrued income490/1€16,324€25,242▲
Equity and liabilities
Total equity and liabilities10/49€108,754€291,572▲
Equity10/15€100,697€284,737▲
Contributions10/11€2,000€2,000=
Profit (loss) carried forward14€98,697€282,737▲
Amounts payable17/49€8,057€6,835▼
Amounts payable within one year42/48€8,057€6,835▼
Trade debts44-€293
Suppliers440/4-€293
Taxes, remuneration and social security45€7,876€6,542▼
Taxes450/3€7,876€6,542▼
Other amounts payable47/48€181-
Income statement Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,877€6,996▲
Other operating charges640/8€1,251€1,692▲
Gross operating margin9900€133,794€254,356▲
Operating profit (loss)9901€127,665€245,667▲
Financial charges65/66B€92€86▼
Recurring financial charges65€92€86▼
Profit (loss) for the period before taxes9903€127,573€245,581▲
Income taxes67/77€28,876€61,542▲
Profit (loss) for the period9904€98,697€184,040▲
Profit (loss) for the period to be appropriated9905€98,697€184,040▲
Appropriation of the result
Profit (loss) to be appropriated9906€98,697€282,737▲
Profit (loss) brought forward from the previous period14P-€98,697

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20232024Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,877€6,996▲ 43.5%
Other operating charges640/8€1,251€1,692▲ 35.2%
Gross operating margin9900€133,794€254,356▲ 90.1%
Operating profit (loss)9901€127,665€245,667▲ 92.4%
Financial charges65/66B€92€86▼ 6.5%
Recurring financial charges65€92€86▼ 6.5%
Profit (loss) for the period before taxes9903€127,573€245,581▲ 92.5%
Income taxes67/77€28,876€61,542▲ 113%
Profit (loss) for the period9904€98,697€184,040▲ 86.5%
Profit (loss) for the period to be appropriated9905€98,697€184,040▲ 86.5%
Line20232024Change
Assets
Total assets20/58€108,754€291,572▲ 168%
Fixed assets21/28€15,318€11,876▼ 22.5%
Tangible fixed assets22/27€15,318€11,876▼ 22.5%
Furniture and vehicles24€15,318€11,876▼ 22.5%
Current assets29/58€93,436€279,696▲ 199%
Amounts receivable within one year40/41€0€2,999▲ 9,995,600%
Trade receivables40€0--
Other amounts receivable41-€2,999-
Current investments50/53-€80,000-
Cash at bank and in hand54/58€77,111€171,455▲ 122%
Deferred charges and accrued income490/1€16,324€25,242▲ 54.6%
Equity and liabilities
Total equity and liabilities10/49€108,754€291,572▲ 168%
Equity10/15€100,697€284,737▲ 183%
Contributions10/11€2,000€2,000=
Profit (loss) carried forward14€98,697€282,737▲ 186%
Amounts payable17/49€8,057€6,835▼ 15.2%
Amounts payable within one year42/48€8,057€6,835▼ 15.2%
Trade debts44-€293-
Suppliers440/4-€293-
Taxes, remuneration and social security45€7,876€6,542▼ 16.9%
Taxes450/3€7,876€6,542▼ 16.9%
Other amounts payable47/48€181--
Line20232024Change
Profit (loss) for the period9904€98,697€184,040▲ 86.5%
+ Depreciation and write-downs630€4,877€6,996▲ 43.5%
Operating cash flow (approximation)€103,574€191,036▲ 84.4%
Investment in fixed assets (approximation)--€3,554-
Change in cash-€94,343-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
29-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
22-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Liquidity quadruplescurrent ratio 40.92
Current ratio from 11.60 to 40.92; short-term debt falls from €8,057 to €6,835.
31-12
Financial Equity above €200,000Eq €284,737 ▲183%
2 profitable years in a row build equity to €284,737.
22-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Waterloo · 1 establishment unit since 2023
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Avenue Scott (Sir Walter) 171410 Waterloo
Ground area
427 m²
Building footprint
210 m²
Volume, LiDAR
2,641 m³
Parcel 21016B0025/00X003, Brussels · tallest building 21.0 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
NS MEDIC
Postiljonstraat 30, 1180 UkkelSpecialist medical practice
since 20232.342.929.882
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21016B0025/00X003 Brussels 427 m² 1 · 210 m² 21.0 m · 5 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,625 companies in sector 86220 we hold annual accounts for 7,987. 6,683 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded07-03-2023
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Contact
E-mail ns.medic@icloud.com
Phone +32477224978
E-invoicing
Reachable via Peppol
Peppol ID 0208:0799234072
Registered 13-02-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.